Live Well with Michelle

Money and Me: The Great Singapore Investing Debate - Singtel, DBS, REITs or the STI?

28 min · 15 de jun de 2026
Portada del episodio Money and Me: The Great Singapore Investing Debate - Singtel, DBS, REITs or the STI?

Descripción

Hosted by Michelle Martin, this episode brings together Willie Keng of Dividend Titan (https://www.dividendtitan.com) and Paul Chew of Phillip Securities for a high-stakes debate on some of the market's biggest investment questions. Has Singtel transformed itself from a steady telco into a compelling AI and digital infrastructure play, or has the market already priced in the good news? Is DBS still Singapore's crown jewel, or are investors paying too much for quality after a decade of stellar returns? The bulls and bears clash over whether Singapore REITs are finally back, whether the STI's best years still lie ahead, and whether investors should stick with the Magnificent Seven or start looking elsewhere. See omnystudio.com/listener [https://omnystudio.com/listener] for privacy information.

Comentarios

0

Sé la primera persona en comentar

¡Regístrate ahora y únete a la comunidad de Live Well with Michelle!

Prueba gratis

Empieza 7 días de prueba

$99 / mes después de la prueba. · Cancela cuando quieras.

  • Podcasts solo en Podimo
  • 20 horas de audiolibros al mes
  • Podcast gratuitos

Todos los episodios

300 episodios

episode LIVE WELL WITH MICHELLE: Beyond Willpower, The New Science of Weight Loss artwork

LIVE WELL WITH MICHELLE: Beyond Willpower, The New Science of Weight Loss

Michelle speaks with the first Gastroenterologist in Singapore to be recognised as a National Fellow by World Obesity Federation, to find out about advances in weight control. As science transforms our understanding of obesity, experts now recognise it as a chronic disease shaped by biology, hormones and the brain - not just lifestyle choices. Hosted by Michelle Martin in conversation with Dr Ravishankar Asok-kumar, Senior Consultant, Gastroenterologist and Advanced Therapeutic Endoscopist at Singapore General Hospital, this episode explores why weight regain is so common, where GLP-1 medications and new minimally invasive treatments fit, and why personalised obesity care could change not just our weight, but our long-term health, confidence and quality of life.  See omnystudio.com/listener [https://omnystudio.com/listener] for privacy information.

Ayer24 min